Skip to main content
Journal of Medical Toxicology logoLink to Journal of Medical Toxicology
letter
. 2010 May 4;6(2):276–277. doi: 10.1007/s13181-010-0084-8

Bupropion, Bayesian Logic and Serotonin Toxicity

P Ken Gillman 1,
PMCID: PMC3550296  PMID: 20440594

Full Text

The Full Text of this article is available as a PDF (60.1 KB).

Acknowledgments

Conflicts of interest

None.

References

  • 1.Thorpe EL, Pizon AF, Lynch MJ, Boyer J (2010) Bupropion induced serotonin syndrome: a case report. J Med Toxicol Mar 18 PMID:20238197. doi:dx.doi.org/10.1007/s13181-010-0021-x [DOI] [PMC free article] [PubMed]
  • 2.Gillman PK. Extracting value from case reports: lessons from serotonin toxicity. Anaesthesia. 2006;61:419–422. doi: 10.1111/j.1365-2044.2006.04588.x. [DOI] [PubMed] [Google Scholar]
  • 3.Gillman PK. A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action. Biol Psychiatry. 2006;59(11):1046–1051. doi: 10.1016/j.biopsych.2005.11.016. [DOI] [PubMed] [Google Scholar]
  • 4.Buckley NA, Whyte IM, Dawson AH. Diagnostic data in clinical toxicology—should we use a Bayesian approach? J Toxicol Clin Toxicol. 2002;40(3):213–222. doi: 10.1081/clt-120005491. [DOI] [PubMed] [Google Scholar]
  • 5.Gillman PK. Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review. Headache. 2009;50:264–272. doi: 10.1111/j.1526-4610.2009.01575.x. [DOI] [PubMed] [Google Scholar]
  • 6.Gillman PK. A systematic review of the serotonergic effects of mirtazapine: implications for its dual action status. Hum Psychopharmacol. 2006;21:117–125. doi: 10.1002/hup.750. [DOI] [PubMed] [Google Scholar]
  • 7.Millan MJ, Gobert A, Rivet JM, Adhumeau-Auclair A, Cussac D, Newman-Tancredi A, et al. Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram. Eur J Neurosci. 2000;12(3):1079–1095. doi: 10.1046/j.1460-9568.2000.00982.x. [DOI] [PubMed] [Google Scholar]
  • 8.Waring WS, Good AM, Bateman DN. Lack of significant toxicity after mirtazapine overdose: a five-year review of cases admitted to a regional toxicology unit. Clin Toxicol (Phila) 2007;45(1):45–50. doi: 10.1080/15563650601005837. [DOI] [PubMed] [Google Scholar]
  • 9.Piacentini MF, Clinckers R, Meeusen R, Sarre S, Ebinger G, Michotte Y. Effect of bupropion on hippocampal neurotransmitters and on peripheral hormonal concentrations in the rat. J Appl Physiol. 2003;95(2):652–656. doi: 10.1152/japplphysiol.01058.2002. [DOI] [PubMed] [Google Scholar]
  • 10.Tatsumi M, Groshan K, Blakely RD, Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997;340(2–3):249–258. doi: 10.1016/s0014-2999(97)01393-9. [DOI] [PubMed] [Google Scholar]
  • 11.Balit CR, Lynch CN, Isbister GK. Bupropion poisoning: a case series. Med J Aust. 2003;178(2):61–63. doi: 10.5694/j.1326-5377.2003.tb05064.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Toxicology are provided here courtesy of Springer

RESOURCES